iwCLL 2019 | Predicting suboptimal response through intermediate MRD

Andrew Rawstron

Andrew Rawstron, PhD, Leeds Teaching Hospitals NHS Trust, Leeds, UK, speaking at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK. Dr Rawston speaks on the predicting suboptimal response through intermediate measurable residual disease (MRD).

Share this video